Oculis Holding AGOCS

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$9.41
Market cap
—
P/E
—
Revenue (FY)
$1.2M
Net income
-$99.0M
Dividend yield
—
1-year total return
-46.2%
Net margin
-8253.3%
Revenue growth
74.8%
Debt / equity
—

What Oculis Holding AG does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$993,000$960,000$912,000$883,000$686,000$1.2M
Net income-$14.9M-$18.6M-$38.7M-$88.8M-$85.8M-$99.0M
Free cash flow-$12.0M-$13.9M-$25.1M-$55.1M-$49.1M-$66.6M

More on OCS.

Figures from Oculis Holding AG's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.